DEC 14, 2017 6:00 AM PST

WEBINAR: Laboratory Diagnosis of von Willebrand Disease (VWD)

Sponsored by: Abbott Diagnostics
Speaker
  • Manager, Medical and Scientific Affairs, Hematology, Abbott Diagnostics
    Biography
      Dr. Larry Smith received his doctorate in biological sciences from Fordham University, Bronx, New York, and completed his certificate in molecular laboratory diagnostics at Michigan State University, East Lansing, Michigan. He completed his postdoctoral studies in gene therapy and experimental hematopoiesis at Columbia University College of Physicians and Surgeons, New York, New York, and was a research fellow in immunology at Fordham University and at the Laboratory of Lymphokine Biology at the New York Blood Center's Lindsley F. Kimball Research Institute, New York, New York. In addition, Dr. Smith has a Master of Science in medical biology and a Bachelor of Science in French and biology.

      His former positions include Research Associate and Director of the Stem Cell Research Laboratory, Division of Hematology-Oncology, at Long Island College Hospital, Brooklyn, New York; Adjunct Associate Professor at Rutgers School of Health Related Professions, Newark, New Jersey; Adjunct Professor at the School of Health Sciences and Professional Programs, York College, City University of New York, Jamaica, New York; and Director of the Coagulation and Hemostasis Laboratories, Assistant Attending Laboratory Scientist for the Department of Clinical Laboratories, and Associate Director of Clinical Hematology Laboratories at Memorial Sloan Kettering Cancer Center, New York, New York.

      Dr. Smith is a member of the American Association for Clinical Chemistry, the Academy of Clinical Laboratory Physicians and Scientists, the American Society for Clinical Pathology, the American Society of Clinical Laboratory Science, the American Society of Hematology, the International Academy of Clinical and Applied Thrombosis/Hemostasis, the International Society for Laboratory Hematology, and the International Society on Thrombosis and Hemostasis.

      Dr. Smith holds multiple board certificates and has published numerous peer-reviewed articles, abstracts, reviews and monographs. He is the co-author of several textbooks on hematology and coagulation and has been an invited presenter at both national and international conferences. His research interests include laboratory test development for hemostasis and coagulation, HPC therapeutic applications, and flow cytometry.

    Abstract

    DATE: December 14, 2017
    TIME: 06:00am PST, 09:00am EST, 3:00pm CET

    von Willebrand Disease (vWD) is one of the most common congenital bleeding disorders, affecting ~1%* of the world’s population. An accurate diagnosis can be very challenging due to the heterogeneity of the disorder and preanalytical variables that may affect the assays used in the diagnosis. Clinical laboratories may perform both screening and complex assays to measure different properties and activities of von Willebrand factor (vWF) to aid clinicians with diagnosis. However, these assays may be adversely affected by preanalytical variables and often have altered performance characteristics that may contribute to inadequate interpretation.

    In this webinar, Dr. Larry Smith, Abbott’s coagulation expert with over 30 years of clinical laboratory experience, will:

    • Define vWD and its history
    • Go over current classification of vWD and assays utilized
    • Review structure and function of vWF
    • Discuss methods/technologies for diagnosing vWD, assay limitations, and preanalytical variables influencing vWD testing and interpretation

     

    Don’t miss a future webinar. Sign up today to receive updates.

     

    *Source: World Federation of Hemophilia.

     


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    Loading Comments...
    Show Resources
    Attendees
    • See more